Clinical trial
The Vienna Prograf and Endothelial Progenitor Cell Extension Study
NCT03751332 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Vienna Prograf and Endothelial Progenitor Cell Extension Study
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- October 31, 2010
- Enrollment
- 87 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
immunosuppression, renal failure